2m 2m 2m 2m 2m 2m 2m
Cullinan Thera (CGEM)
NASDAQ
$17.65-$0.23 (-1.26%)
Price as of Jul 14, 2026 5:43 AM EDT- $1.1BMarket Cap
- 127.06%1-Year Change
- BiotechnologyIndustry
Cullinan Thera (CGEM)
$17.65-$0.23 (-1.26%)
CGEM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.87 | ||
Change | -$0.26 (-1.43%) | ||
Open | $17.76 | ||
High | $18.20 | ||
Low | $17.29 | ||
Previous Close | $18.13 | ||
Volume | 651,881 | ||
30-Day Average Volume | 1,250,469 | ||
1-Week Change | 0.34% | ||
1-Month Change | 30.44% | ||
1-Year Change | 127.06% | ||
3-Year Change | 55.12% | ||
5-Year Change | -39.73% | ||
Fundamentals | |||
Shares Outstanding | 61.5M | ||
Total Assets | $403.0M | ||
Market Cap | $1.1B | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$45.5M | ||
Free Cash Flow | -$46.0M | ||
EBIT | -$45.5M | ||
EBITDA | -$45.4M | ||
Net Working Capital | $326.3M | ||
EPS | -$0.75 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -24 | ||
PEG | -2 | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 08/31/2009 | ||
Earnings & Revenue